COCP (Cocrystal Pharma, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings
Cocrystal Pharma, Inc. Common Stock (COCP) is a publicly traded Healthcare sector company. As of May 21, 2026, COCP trades at $1.13 with a market cap of $16.27M and a P/E ratio of -1.42. COCP moved -2.61% today. Year to date, COCP is +1.83%; over the trailing twelve months it is -26.73%. Its 52-week range spans $0.86 to $3.26. Analyst consensus is buy with an average price target of $6.00. Rallies surfaces COCP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns COCP stock?
Hedge funds tracked by Rallies that own COCP include Renaissance Technologies. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Cocrystal Pharma, Inc. Common Stock.
COCP Key Metrics
Key financial metrics for COCP
Metric
Value
Price
$1.13
Market Cap
$16.27M
P/E Ratio
-1.42
EPS
$-0.78
Dividend Yield
0.00%
52-Week High
$3.26
52-Week Low
$0.86
Volume
25
Avg Volume
0
Revenue (TTM)
$0
Net Income
$-8.83M
Gross Margin
0.00%
Top Hedge Funds Holding COCP
Renaissance Technologies holds 125.83K shares of COCP, changed -3.23% as of Dec 31, 2024.
Hedge funds tracked by Rallies that own COCP include Renaissance Technologies. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Cocrystal Pharma, Inc. Common Stock.
Does Rallies show 13F holders for COCP?
Yes. Rallies tracks hedge fund and 13F ownership data for COCP, including fund names, share counts, latest tracked quarter, and position changes when available.
Is COCP research on Rallies investment advice?
No. Rallies provides research, data, and educational context for COCP. It does not provide personalized investment advice.